Drugs / L-DOPA/DDCI
last change Apr 2023 re-read 2 minutes ago

L-DOPA/DDCI

Developed for
Parkinson disease
Investigated by
Bial - Portela C S.A.

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04990284 Nov 2021 → Apr 2023 Parkinson disease Bial - Portela C S.A. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as L-DOPA/DDCI ClinicalTrials.gov intervention name — accepted as the source's own label NCT04990284